Literature DB >> 8948612

Acid-induced laryngospasm in a canine model.

C J Loughlin1, J A Koufman, D B Averill, M M Cummins, Y J Kim, J P Little, I J Miller, J W Meredith.   

Abstract

A canine model was used to investigate the efferent laryngeal responses to stimulation by topically applied acid and pepsin. Five adult mongrel dogs were studied. Electromyographic recordings from the thyroarytenoid muscle were measured with hooked-wire electrodes as an acid solution (normal saline/hydrochloric acid at pH 6.0, 5.0, 4.0, 3.0, 2.5, 2.0, 1.5, and 1.0) was sequentially instilled into the larynx. Laryngospasm (tonic, sustained contraction of the thyroarytenoid muscle) occurred in all animals at pH 2.5 to 2.0 or less. Control substances such as neutral pH isotonic saline, hypotonic saline, hypertonic saline, water, and pepsin alone failed to produce laryngospasm. Next, solutions containing both acid (in the same pH range) and pepsin were tested. The laryngeal responses were similar to those of acid alone. The superior laryngeal nerves were sectioned bilaterally and the above experiments repeated. None of the test solutions produced laryngospasm; however, when capsaicin (1%) was instilled into the subglottis, laryngospasm occurred. Thus, chemoreceptors in the subglottis (supplied by the recurrent laryngeal nerves) appear to be responsive to capsaicin stimulation but not to acid stimulation. The data suggest that pH-sensitive chemoreceptors in the canine larynx cause laryngospasm (when the pH of the test solution is 2.5 or less) and that these acid receptors are supplied by the superior laryngeal nerves.

Entities:  

Mesh:

Year:  1996        PMID: 8948612     DOI: 10.1097/00005537-199612000-00012

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  16 in total

Review 1.  Paradoxical vocal cord motion disorder: past, present and future.

Authors:  Wanis H Ibrahim; Heitham A Gheriani; Ahmed A Almohamed; Tasleem Raza
Journal:  Postgrad Med J       Date:  2007-03       Impact factor: 2.401

Review 2.  Laryngopharyngeal reflux: the value of otolaryngology examination.

Authors:  Peter C Belafsky; Catherine J Rees
Journal:  Curr Gastroenterol Rep       Date:  2008-06

Review 3.  Gastroesophageal reflux/laryngopharyngeal reflux disease: a critical analysis of the literature.

Authors:  M N Kotby; O Hassan; Aly M N El-Makhzangy; M Farahat; P Milad
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-02       Impact factor: 2.503

4.  Laryngopharyngeal Reflux and Functional Laryngeal Disorder: Perspective and Common Practice of the General Gastroenterologist.

Authors:  Dhyanesh A Patel; Michael Blanco; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-09

5.  Eye reflux: an ocular extraesophageal manifestation of gastric reflux.

Authors:  Danilo Mazzacane; Valerio Damiani; Michela Silvestri; Giorgio Ciprandi; Pierfranco Marino
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

Review 6.  Laryngeal Chemoreflex in Health and Disease: A Review.

Authors:  Shivani Pathak; Laurie Slovarp; Matthew S Clary; Marie E Jetté
Journal:  Chem Senses       Date:  2020-12-05       Impact factor: 3.160

7.  Laryngeal and tracheal afferent nerve stimulation evokes swallowing in anaesthetized guinea pigs.

Authors:  Takanori Tsujimura; Chioma Udemgba; Makoto Inoue; Brendan J Canning
Journal:  J Physiol       Date:  2013-07-15       Impact factor: 5.182

Review 8.  Laryngeal manifestations of gastroesophageal reflux disease.

Authors:  Michael F Vaezi
Journal:  Curr Gastroenterol Rep       Date:  2008-06

Review 9.  Severe obstructive airway disorders and diseases: vocal fold dysfunction.

Authors:  Katherine A Kendall; Samuel Louie
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

10.  Paradoxical vocal cord dysfunction: clinical experience and personal considerations.

Authors:  A Nacci; B Fattori; F Ursino; V Rocchi; F Matteucci; C Citi; L Bruschini; F Rognini; R La Vela; I Dallan
Journal:  Acta Otorhinolaryngol Ital       Date:  2007-10       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.